Bulletin
Investor Alert

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 1:00 p.m.

/zigman2/quotes/206805265/composite

$

10.27

Change

0.00 0.00%

Volume

Volume 2

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 10.21

$ 10.27

Change

+0.06 +0.59%

Day low

Day high

$9.59

$10.27

Open

52 week low

52 week high

$5.13

$12.99

Open

Richard L. Lindstrom

Richard L. Lindstrom is a businessperson who founded Minnesota Eye Consultants PA and Phillips Eye Institute and who has been at the head of 8 different companies. He occupies the position of Chairman, President & Chief Executive Officer at Lindstrom Restoration, Medical Director at Sightpath Medical, Inc., Partner at Flying L Management LLC, Principal at Visionary Ventures Management LLC, Chief Executive Officer for Minnesota Eye Consultants PA and Medical Director at Midwest Surgical Services, Inc. Richard L. Lindstrom is also Chairman for American Society of Cataract & Refractive Surgery Foundation and Professor-Emeritus at the University of Minnesota and on the board of 21 other companies.

In the past Dr. Lindstrom was Chairman for Vision Foundation, Inc., President for International Refractive Surgery Club, Director & Chief Medical Officer at TLC Vision Corp., President of International Society of Refractive Surgery, Director at Refractec, Inc., President for International Intra-Ocular Implant Club, President at The American Society of Cataract & Refractive Surgery and Associate Director at Minnesota Lions Vision Foundation, Inc.

He received a doctorate and an undergraduate degree from The College of Liberal Arts at the University of Minnesota.

Transactions

Date Shares Transaction Value
09/24/2021 3,900   Disposition at $10.04 per share. 39,156
09/16/2021 5,840   Disposition at $9.02 per share. 52,677
09/15/2021 14,160   Disposition at $9.09 per share. 128,715
05/20/2021 10,000   Disposition at $10.75 per share. 107,500
04/27/2017 100,000   179,000
12/19/2016 100,000   Acquisition at $1.79 per share. 179,000

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Dr. Larry M. Dillaha
Chief Medical Officer
Mr. Andrew Livingston
Chief Innovation Officer
Mr. John P. Saharek
President-ImprimisRx
Dr. Richard L. Lindstrom
Director
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence Van Horn
Independent Director
Dr. Robert J. Kammer
Independent Director
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.